Skip to main content
Top
Published in: Archives of Gynecology and Obstetrics 3/2012

01-03-2012 | Maternal-Fetal Medicine

Single dose 17 alpha-hydroxyprogesterone caproate in preterm labor: a randomized trial

Authors: Peng Chiong Tan, Anthonia Siaw Jia King, Narayanan Vallikkannu, Siti Zawiah Omar

Published in: Archives of Gynecology and Obstetrics | Issue 3/2012

Login to get access

Abstract

Objective

To evaluate the effect of a single 250-mg dose of 17 alpha-hydroxyprogesterone caproate (17-OHPC) intramuscularly as adjunct to nifedipine tocolysis in preterm labor.

Method

Women diagnosed with threatened preterm labor between 22 and 35 weeks’ gestation scheduled to receive nifedipine tocolysis and prophylactic antenatal corticosteroid were randomized to a single intramuscular injection of 250 mg of 17-OHPC or placebo saline in a double-blind fashion. Nifedipine tocolysis and corticosteroids were administered to all participants. Further management was otherwise carried out according to providers’ discretion. Main outcome measures are delivery within 48 h and 7 days.

Results

Data were analyzed for the 56 participants randomized to 17-OHPC and 56 randomized to placebo. Delivery rates within 48 h were 11/54 (20.4%) versus 15/56 (26.8%) RR 0.76 (95% CI 0.38–1.51) and within 7 days were 13/52 (25.0%) versus 19/54 (35.2%) RR 0.71 (95% CI 0.39–1.29) for 17-OHPC and placebo groups, respectively, and were similar. Recruitment to delivery interval, gestation at delivery, delivery rate before 34 weeks’ and 37 weeks’ gestation, and neonatal outcomes were also similar.

Conclusion

The results indicated that adjunctive single-dose 17-OHPC in combination with nifedipine tocolysis for threatened preterm labor did not delay delivery.
Literature
1.
2.
go back to reference Gibson AT (2007) Outcome following preterm birth. Best Pract Res Clin Obstet Gynaecol 21(5):869–882PubMedCrossRef Gibson AT (2007) Outcome following preterm birth. Best Pract Res Clin Obstet Gynaecol 21(5):869–882PubMedCrossRef
3.
go back to reference Swamy GK, Ostbye T, Skjaerven R (2008) Association of preterm birth with long-term survival, reproduction, and next-generation preterm birth. JAMA 299(12):1429–1436PubMedCrossRef Swamy GK, Ostbye T, Skjaerven R (2008) Association of preterm birth with long-term survival, reproduction, and next-generation preterm birth. JAMA 299(12):1429–1436PubMedCrossRef
4.
go back to reference Moster D, Lie RT, Markestad T (2008) Long-term medical and social consequences of preterm birth. N Engl J Med 359(3):262–273PubMedCrossRef Moster D, Lie RT, Markestad T (2008) Long-term medical and social consequences of preterm birth. N Engl J Med 359(3):262–273PubMedCrossRef
5.
go back to reference Roberts D, Dalziel S (2006) Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 3:CD004454PubMed Roberts D, Dalziel S (2006) Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 3:CD004454PubMed
6.
go back to reference Waters TP, Mercer B (2009) Impact of timing of antenatal corticosteroid exposure on neonatal outcomes. J Matern Fetal Neonatal Med 22(4):311–314PubMedCrossRef Waters TP, Mercer B (2009) Impact of timing of antenatal corticosteroid exposure on neonatal outcomes. J Matern Fetal Neonatal Med 22(4):311–314PubMedCrossRef
9.
go back to reference Lachelin GC, McGarrigle HH, Seed PT, Briley A, Shennan AH, Poston L (2009) Low saliva progesterone concentrations are associated with spontaneous early preterm labour (before 34 weeks of gestation) in women at increased risk of preterm delivery. BJOG 116(11):1515–1519PubMedCrossRef Lachelin GC, McGarrigle HH, Seed PT, Briley A, Shennan AH, Poston L (2009) Low saliva progesterone concentrations are associated with spontaneous early preterm labour (before 34 weeks of gestation) in women at increased risk of preterm delivery. BJOG 116(11):1515–1519PubMedCrossRef
10.
go back to reference Stamatelou F, Deligeoroglou E, Farmakides G, Creatsas G (2009) Abnormal progesterone and corticotropin releasing hormone levels are associated with preterm labour. Ann Acad Med Singapore 38(11):1011–1016PubMed Stamatelou F, Deligeoroglou E, Farmakides G, Creatsas G (2009) Abnormal progesterone and corticotropin releasing hormone levels are associated with preterm labour. Ann Acad Med Singapore 38(11):1011–1016PubMed
11.
go back to reference Bell R (1983) Antenatal oestradiol and progesterone concentrations in patients subsequently having preterm labour. Br J Obstet Gynaecol 90(10):888–891PubMedCrossRef Bell R (1983) Antenatal oestradiol and progesterone concentrations in patients subsequently having preterm labour. Br J Obstet Gynaecol 90(10):888–891PubMedCrossRef
12.
go back to reference Smit DA, Essed GG, de Haan J (1984) Predictive value of uterine contractility and the serum levels of progesterone and oestrogens with regard to preterm labour. Gynecol Obstet Invest 18(5):252–263PubMedCrossRef Smit DA, Essed GG, de Haan J (1984) Predictive value of uterine contractility and the serum levels of progesterone and oestrogens with regard to preterm labour. Gynecol Obstet Invest 18(5):252–263PubMedCrossRef
13.
go back to reference Dodd JM, Flenady VJ, Cincotta R, Crowther CA (2008) Progesterone for the prevention of preterm birth: a systematic review. Obstet Gynecol 112(1):127–134PubMedCrossRef Dodd JM, Flenady VJ, Cincotta R, Crowther CA (2008) Progesterone for the prevention of preterm birth: a systematic review. Obstet Gynecol 112(1):127–134PubMedCrossRef
14.
go back to reference Su LL, Samuel M, Chong YS (2010) Progestational agents for treating threatened or established preterm labour. Cochrane Database Syst Rev (1):CD006770 Su LL, Samuel M, Chong YS (2010) Progestational agents for treating threatened or established preterm labour. Cochrane Database Syst Rev (1):CD006770
15.
go back to reference Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH, Spong CY, Hauth JC, Miodovnik M, Varner MW et al (2003) Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 348(24):2379–2385PubMedCrossRef Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH, Spong CY, Hauth JC, Miodovnik M, Varner MW et al (2003) Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 348(24):2379–2385PubMedCrossRef
16.
go back to reference Zakar T, Mesiano S (2011) How does progesterone relax the uterus in pregnancy? N Engl J Med 364(10):972–973PubMedCrossRef Zakar T, Mesiano S (2011) How does progesterone relax the uterus in pregnancy? N Engl J Med 364(10):972–973PubMedCrossRef
17.
go back to reference Renthal NE, Chen CC, Williams KC, Gerard RD, Prange-Kiel J, Mendelson CR (2010) miR-200 family and targets, ZEB1 and ZEB2, modulate uterine quiescence and contractility during pregnancy and labor. Proc Natl Acad Sci USA 107(48):20828–20833PubMedCrossRef Renthal NE, Chen CC, Williams KC, Gerard RD, Prange-Kiel J, Mendelson CR (2010) miR-200 family and targets, ZEB1 and ZEB2, modulate uterine quiescence and contractility during pregnancy and labor. Proc Natl Acad Sci USA 107(48):20828–20833PubMedCrossRef
18.
go back to reference King JF, Flenady VJ, Papatsonis DN, Dekker GA, Carbonne B (2003) Calcium channel blockers for inhibiting preterm labour. Cochrane Database Syst Rev (1):CD002255 King JF, Flenady VJ, Papatsonis DN, Dekker GA, Carbonne B (2003) Calcium channel blockers for inhibiting preterm labour. Cochrane Database Syst Rev (1):CD002255
19.
go back to reference Fuchs F, Stakemann G (1960) Treatment of threatened premature labor with large doses of progesterone. Am J Obstet Gynecol 79:172–176PubMed Fuchs F, Stakemann G (1960) Treatment of threatened premature labor with large doses of progesterone. Am J Obstet Gynecol 79:172–176PubMed
20.
go back to reference Erny R, Pigne A, Prouvost C, Gamerre M, Malet C, Serment H, Barrat J (1986) The effects of oral administration of progesterone for premature labor. Am J Obstet Gynecol 154(3):525–529PubMed Erny R, Pigne A, Prouvost C, Gamerre M, Malet C, Serment H, Barrat J (1986) The effects of oral administration of progesterone for premature labor. Am J Obstet Gynecol 154(3):525–529PubMed
21.
go back to reference Facchinetti F, Paganelli S, Comitini G, Dante G, Volpe A (2007) Cervical length changes during preterm cervical ripening: effects of 17-alpha-hydroxyprogesterone caproate. Am J Obstet Gynecol 196(5):453 (e1–4; discussion 421)PubMedCrossRef Facchinetti F, Paganelli S, Comitini G, Dante G, Volpe A (2007) Cervical length changes during preterm cervical ripening: effects of 17-alpha-hydroxyprogesterone caproate. Am J Obstet Gynecol 196(5):453 (e1–4; discussion 421)PubMedCrossRef
22.
go back to reference Noblot G, Audra P, Dargent D, Faguer B, Mellier G (1991) The use of micronized progesterone in the treatment of menace of preterm delivery. Eur J Obstet Gynecol Reprod Biol 40(3):203–209PubMedCrossRef Noblot G, Audra P, Dargent D, Faguer B, Mellier G (1991) The use of micronized progesterone in the treatment of menace of preterm delivery. Eur J Obstet Gynecol Reprod Biol 40(3):203–209PubMedCrossRef
23.
go back to reference Facchinetti F, Dante G, Venturini P, Paganelli S, Volpe A (2008) 17alpha-hydroxy-progesterone effects on cervical proinflammatory agents in women at risk for preterm delivery. Am J Perinatol 25(8):503–506PubMedCrossRef Facchinetti F, Dante G, Venturini P, Paganelli S, Volpe A (2008) 17alpha-hydroxy-progesterone effects on cervical proinflammatory agents in women at risk for preterm delivery. Am J Perinatol 25(8):503–506PubMedCrossRef
24.
go back to reference Borna S, Sahabi N (2008) Progesterone for maintenance tocolytic therapy after threatened preterm labour: a randomised controlled trial. Aust N Z J Obstet Gynaecol 48(1):58–63PubMedCrossRef Borna S, Sahabi N (2008) Progesterone for maintenance tocolytic therapy after threatened preterm labour: a randomised controlled trial. Aust N Z J Obstet Gynaecol 48(1):58–63PubMedCrossRef
25.
go back to reference Ruddock NK, Shi SQ, Jain S, Moore G, Hankins GD, Romero R, Garfield RE (2008) Progesterone, but not 17-alpha-hydroxyprogesterone caproate, inhibits human myometrial contractions. Am J Obstet Gynecol 199(4):391 (e1–7)PubMedCrossRef Ruddock NK, Shi SQ, Jain S, Moore G, Hankins GD, Romero R, Garfield RE (2008) Progesterone, but not 17-alpha-hydroxyprogesterone caproate, inhibits human myometrial contractions. Am J Obstet Gynecol 199(4):391 (e1–7)PubMedCrossRef
26.
go back to reference Anderson L, Martin W, Higgins C, Nelson SM, Norman JE (2009) The effect of progesterone on myometrial contractility, potassium channels, and tocolytic efficacy. Reprod Sci 16(11):1052–1061PubMedCrossRef Anderson L, Martin W, Higgins C, Nelson SM, Norman JE (2009) The effect of progesterone on myometrial contractility, potassium channels, and tocolytic efficacy. Reprod Sci 16(11):1052–1061PubMedCrossRef
27.
go back to reference O’Brien JM, Ho SJ, Istwan NB, Stanziano GJ, Rhea DJ, Barton JR (2010) Uterine activity in women receiving 17 alpha-hydroxyprogesterone caproate for the prevention of preterm birth: an observational study. Am J Perinatol 27(2):157–162 O’Brien JM, Ho SJ, Istwan NB, Stanziano GJ, Rhea DJ, Barton JR (2010) Uterine activity in women receiving 17 alpha-hydroxyprogesterone caproate for the prevention of preterm birth: an observational study. Am J Perinatol 27(2):157–162
Metadata
Title
Single dose 17 alpha-hydroxyprogesterone caproate in preterm labor: a randomized trial
Authors
Peng Chiong Tan
Anthonia Siaw Jia King
Narayanan Vallikkannu
Siti Zawiah Omar
Publication date
01-03-2012
Publisher
Springer-Verlag
Published in
Archives of Gynecology and Obstetrics / Issue 3/2012
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-011-2026-3

Other articles of this Issue 3/2012

Archives of Gynecology and Obstetrics 3/2012 Go to the issue